Lucid Diagnostics (LUCD) Revenue & Revenue Breakdown
Lucid Diagnostics Revenue Highlights
Latest Revenue (Y)
$4.35B
Latest Revenue (Q)
$1.16B
Lucid Diagnostics Revenue by Period
Lucid Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $4.35B | 178895.06% |
| 2023-12-31 | $2.43M | 544.03% |
| 2022-12-31 | $377.00K | -24.60% |
| 2021-12-31 | $500.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Lucid Diagnostics generated $4.35B in revenue during NA 2024, up 178895.06% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Lucid Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $1.16B | 140358.94% |
| 2025-03-31 | $828.00K | -30.83% |
| 2024-12-31 | $1.20M | 2.13% |
| 2024-09-30 | $1.17M | 20.08% |
| 2024-06-30 | $976.00K | -2.50% |
| 2024-03-31 | $1.00M | -3.75% |
| 2023-12-31 | $1.04M | 32.82% |
| 2023-09-30 | $783.00K | 392.45% |
| 2023-06-30 | $159.00K | -64.35% |
| 2023-03-31 | $446.00K | 298.21% |
| 2022-12-31 | $112.00K | 47.37% |
| 2022-09-30 | $76.00K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $189.00K | -37.00% |
| 2021-12-31 | $300.00K | 50.00% |
| 2021-09-30 | $200.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Lucid Diagnostics generated $1.16B in revenue during Q2 2025, up 140358.94% compared to the previous quarter, and up 116183.82% compared to the same period a year ago.
Lucid Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LUCD | Lucid Diagnostics | $4.35B | $1.16B |
| ANIK | Anika Therapeutics | $166.66M | $28.22M |
| LNSR | LENSAR | $53.49M | $14.16M |
| RCEL | AVITA Medical | $50.56M | $18.51M |
| APYX | Apyx Medical | $48.10M | $9.43M |
| MGX | Metagenomi | $44.76M | $8.51M |
| SEER | Seer | $14.17M | $4.21M |
| IRD | Opus Genetics | $10.99M | $4.37M |
| TCRX | TScan Therapeutics | $2.82M | - |
| IMDX | Insight Molecular Diagnostics | $1.88M | $518.00K |
| HSDT | Solana | $520.00K | $49.00K |